Shares of rare-disease drugmaker Zogenix (NASDAQ: ZGNX) fell 11.4% in August, according to data provided by S&P Global Market Intelligence. That was a much worse performance than the S&P 500, which was only off 1.8% for the month.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,